, Volume 116, Issue 1, pp 125-127
Date: 16 Oct 2008

Neuropsychological studies in breast cancer: in search of chemobrain

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access
This is an excerpt from the content

Earlier detection and diagnosis of breast cancer has resulted in a growing number of patients with non-invasive tumors or localized invasive breast cancers. Among these early-stage patients, survival rates are high and most women can anticipate a normal life expectancy—making understanding and attending to post-treatment quality of life issues particularly pertinent. One area that has received increasing attention over the last several years is cognitive functioning [13], which is known to be strongly related to quality of life. The focus on post-treatment neurocognitive function has grown out of the recognition that a sizeable minority of patients undergoing adjuvant chemotherapy report and/or demonstrate some degree of cognitive compromise.

In this issue of ‘Breast Cancer Research and Treatment’, Quesnel and colleagues [4], report findings from a longitudinal study of early-stage breast cancer patients, (half of whom received adjuvant chemotherapy in addition to radiotherapy, half o

This is an invited commentary to doi:10.1007/s10549-005-9114-7.